Eurofins among top CAC 40 decliners as BofA downgrades
Eurofins Scientific shares are posting one of the sharpest declines on the CAC 40 in Paris trading this Monday, following Bank of America's decision to cut its rating on the stock from 'neutral' to 'underperform'.
As of 11:30 AM, the stock was down more than 1.5% at 58.4 euros, while the CAC 40 retreated by nearly 1% over the same period. The shares have now lost more than 6% since the start of the year.
In a research note published this morning, BofA argues that the core investment thesis for the stock relies on a recovery in biopharmaceutical activities, a rebound that the U.S. bank does not expect to materialize in the immediate future.
AI as a headwind for valuation
Consequently, the firm has lowered its earnings forecasts for the laboratory network by 0.6% to 3.8% for the 2026-2028 period, placing them 3% to 9% below consensus estimates.
'The risk of downward revisions to earnings per share (EPS) estimates, combined with limited potential for multiple rerating (as we view AI-related disruption as a persistent threat), leads us to downgrade our recommendation,' explained BofA, which reduced its price target from 64 to 56 euros.
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2025, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (52,5%), North America (36.8%) and other (10.7%).
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
